Marc Moure-Garcia
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Ad5/52s fiber substitution alters Ad5 tropism, bioavailability, and plasma sensitivity.
Journal: Molecular therapy. Advances
Published: September 08, 2025
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas.
Journal: Cell reports. Medicine
Published: October 08, 2024
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.
Journal: Neuro-oncology
Published: March 30, 2024
A road map for the treatment of pediatric diffuse midline glioma.
Journal: Cancer cell
Published: October 12, 2023
Oncolytic virotherapy for the treatment of pediatric brainstem gliomas.
Journal: Revue neurologique
Published: February 24, 2023
DNA-damaging cancer cells to improve virotherapy.
Journal: Molecular therapy oncolytics
Published: November 02, 2022
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.
Journal: The New England journal of medicine
Published: June 29, 2022
Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma.
Journal: Molecular therapy oncolytics
Published: April 04, 2022
Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory.
Journal: Molecular cancer therapeutics
Published: June 29, 2021
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models.
Journal: Journal for immunotherapy of cancer
Published: June 16, 2021
Last Updated: 09/26/2026